All Stories

  1. Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease

    Article • Leukemia & Lymphoma, February 2023, Taylor & Francis

    Matthew J Newman

  2. Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists

    Article • Journal of Oncology Pharmacy Practice, November 2020, SAGE Publications

    Matthew J Newman

  3. Moxetumomab pasudotox-tdfk for relapsed/refractory hairy cell leukemia: a review of clinical considerations

    Article • Cancer Chemotherapy and Pharmacology, May 2019, Springer Science + Business Media

    Matthew J Newman

  4. Evaluation of the head and neck cancer patient population and the incidence of hospitalization at an academic medical center

    Article • Journal of Oncology Pharmacy Practice, October 2017, SAGE Publications

    Matthew J Newman

  5. Effects of the leucovorin shortage: Pilot study investigating cost, efficacy, and toxicity comparison of low fixed-dose versus body surface area-adjusted leucovorin dosing in patients with resectable colon or metastatic colorectal cancer

    Article • Journal of Oncology Pharmacy Practice, April 2017, SAGE Publications

    Matthew J Newman

  6. Systemic effects of low-dose dopamine during administration of cytarabine

    Article • Journal of Oncology Pharmacy Practice, July 2016, SAGE Publications

    Dr. James Connelly, Matthew J Newman

  7. Azacitidine-Induced Pericarditis: A Case Series

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, April 2016, Wiley

    Matthew J Newman

  8. Blinatumomab - a new drug for acute lymphoblastic leukemia

    Article • Journal of Oncology Pharmacy Practice, November 2015, SAGE Publications

    Matthew J Newman

  9. Nonadministration of thromboprophylaxis in hospitalized patients with HIV: A missed opportunity for prevention?

    Article • Journal of Hospital Medicine, January 2014, Wiley

    Matthew J Newman

  10. Cost-effectiveness of fulvestrant 250 mg versus 500 mg in postmenopausal women with estrogen receptor-positive metastatic breast cancer and disease progression after antiestrogen therapy

    Article • Journal of Oncology Pharmacy Practice, February 2012, SAGE Publications

    Matthew J Newman

  11. Impact of a national propofol shortage on duration of mechanical ventilation at an academic medical center*

    Article • Critical Care Medicine, February 2012, Wolters Kluwer Health

    Matthew J Newman